Preview Mode Links will not work in preview mode

This Week in Cardiology

Oct 8, 2021

Two NEJM papers on mRNA-related myocarditis, AF and stroke, intensifying BP meds, and CCTA and high-sensitivity troponin are the topics John Mandrola, MD, covers in this week's podcast. To read a partial transcript or to comment, visit:

I -- Vaccine-Induced Myocarditis

New Reports Help Nail Down Myocarditis Risk With COVID-19 Vaccine

• Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

• Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

II – AF and Stroke

AF a Stroke Cause or Innocent Bystander? The Debate Continues

• Temporal Association Between Episodes of Atrial Fibrillation and Risk of Ischemic Stroke

• It's Time to Rethink (and Retrial) Our Framework for Stroke Prevention in Atrial Fibrillation

III- Intensification of BP Control

Adding New Hypertensive May Be More Potent Than Upping Doses

• Adding a New Medication Versus Maximizing Dose to Intensify Hypertension Treatment in Older Adults

IV- Hs-troponin and CAD

Troponin Levels Tied to Increased CAD Risk, May Guide Imaging /viewarticle/960146

• Troponin-Guided Coronary Computed Tomographic Angiography After Exclusion of Myocardial Infarction

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact